Agents for the treatment of glycosphingolipid storage disorders.

Agents for the treatment of glycosphingolipid storage disorders.

Item
http://www.wikidata.org/entity/Q34341660
Gaucher disease and the clinical experience with substrate reduction therapy.Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.Gaucher's disease and cancer: a sphingolipid perspectiveGaucher disease: pathological mechanisms and modern management.Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein.Substrate reduction therapy: miglustat as a remedy for symptomatic patients with Gaucher disease type 1.Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.Dissociation of ERK signalling inhibition from the anti-amyloidogenic action of synthetic ceramide analoguesSynthesis and Evaluation of Hybrid Structures Composed of Two Glucosylceramide Synthase Inhibitors.Current and emerging therapies for the lysosomal storage disorders.Review of miglustat for clinical management in Gaucher disease type 1.Glycosphingolipid functionsPhosphorylated glycosphingolipids essential for cholesterol mobilization in Caenorhabditis elegans.Glucosylceramide synthase protects glioblastoma cells against autophagic and apoptotic death induced by temozolomide and Paclitaxel.C-Alkyl 5-membered ring imino sugars as new potent cytotoxic glucosylceramide synthase inhibitors.Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells.
P2860

Agents for the treatment of glycosphingolipid storage disorders.

Item
http://www.wikidata.org/entity/Q34341660
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Agents for the treatment of glycosphingolipid storage disorders.
@ast
Agents for the treatment of glycosphingolipid storage disorders.
@en
Agents for the treatment of glycosphingolipid storage disorders.
@nl
type
label
Agents for the treatment of glycosphingolipid storage disorders.
@ast
Agents for the treatment of glycosphingolipid storage disorders.
@en
Agents for the treatment of glycosphingolipid storage disorders.
@nl
prefLabel
Agents for the treatment of glycosphingolipid storage disorders.
@ast
Agents for the treatment of glycosphingolipid storage disorders.
@en
Agents for the treatment of glycosphingolipid storage disorders.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Agents for the treatment of glycosphingolipid storage disorders.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698